Anti-CD11 Reference Antibody (Rovelizumab), IgG4, Monoclonal

Produktübersicht

• Artikelname: Anti-CD11 Reference Antibody (Rovelizumab), IgG4, Monoclonal
• Artikelnummer: SYB-CHB385
• Hersteller Artikelnummer: CHB385
• Alternativnummer: SYB-CHB385-100UG, SYB-CHB385-1MG
• Hersteller: Sanyou Bio
• Kategorie: Antikörper
• Applikation: ELISA, FA, FACS, Kinetics

Produktbeschreibung

Anti-CD11 Reference Antibody (Rovelizumab)(CHB385) is expressed from CHO. The heavy chain type is IgG4, and the light chain type is kappa. It has a predicted MW of 145.98 kDa.

Produkteigenschaften

• Klonalität: Monoclonal
• Konzentration: 1mg/ml
• Isotyp: IgG4
• UniProt: P11215
• Puffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
• Reinheit: >95%
• Formulierung: Lyophilize
• Target-Kategorie: CD11